elements
-live
Search elements, keywords, and sectors
🔎
Elements
Subjects
Papers
Communities
Lab
API & MCP
Pricing
Log in
Sign up
Home
/
Subjects
/
Ubiquitin ligase
← Back to subjects
Current data, viewed at
Yearly
resolution.
Personal members see monthly resolution →
Keyword
keyword
Ubiquitin ligase
RIS
0.002
(Research Intensity Score)
Papers
176
Top papers
NRF2 controls iron homeostasis and ferroptosis through HERC2 and VAMP8
2023 · 515 citations
Targeted protein degradation via intramolecular bivalent glues
2024 · 196 citations
Antibody targeting of E3 ubiquitin ligases for receptor degradation
2022 · 264 citations
ABCF1-K430-Lactylation promotes HCC malignant progression via transcriptional activation of HIF1 signaling pathway
2025 · 82 citations
CircRNA-SORE mediates sorafenib resistance in hepatocellular carcinoma by stabilizing YBX1
2020 · 573 citations
Newest papers
Rewiring an E3 ligase enhances cold resilience and phosphate use in maize
2026 · 10 citations
UBE2O-mediated monoubiquitination licenses NLRP6 inflammasome activation in the intestine
2026 · 3 citations
Viral inhibition of the anaphase promoting complex enhances replication by elevating nucleotide pools
2026 · 1 citations
Targeting the USP7-PRMT6 epigenetic axis overcomes chemoresistance in breast cancer by coordinating H3R2me2a deposition and RNF168 methylation for DNA repair and ferroptosis blockade
2026 · 2 citations
Inhibiting TRIM21 Neddylation Rejuvenates Oocyte Quality in PCOS by Regulating Ubiquitination of CPT1A
2026 · 2 citations
A sample from the 100 top papers behind Ubiquitin ligase.
Create a free account to browse them all →
Ubiquitin ligase's history
Research intensity over time
Explore Ubiquitin ligase's full history
Hover any year for its value and switch resolutions with a free account. Personal adds monthly detail and the historical-intensity (HRI) line.
Create a free account
Already have an account?
Log in
to explore the data.
Close ✕
Ubiquitin ligase's papers
Ordered by current research-activity contribution.
Loading…
Close ✕
Read full text ↗
Share
Share on X
Share on Facebook
Share on LinkedIn
Copy link